Tyler J Friedrich (Tyler Friedrich)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Locally Advanced

Epidermal Growth Factor Receptor

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, Kimberley R Jordan, Todd M Pitts, Hannah R Robinson, S Lindsey Davis, Sunnie S Kim, Alexis D Leal, Matthew R Lee, Meredith R N Waring, Anne C Martin, Adrian T A Dominguez, Stacey M Bagby, Sarah J Hartman, S Gail Eckhardt, Wells A Messersmith, Christopher H Lieu
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford, Kimberley R Jordan, Todd M Pitts, Hannah R Robinson, S Lindsey Davis, Sunnie S Kim, Alexis D Leal, Matthew R Lee, Meredith R N Waring, Anne C Martin, Adrian T A Dominguez, Stacey M Bagby, Sarah J Hartman, S Gail Eckhardt, Wells A Messersmith, Christopher H Lieu
A phase II study of potentiation of pembrolizumab with binimetinib and bevacizumab in refractory microsatellite stable colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jacob B Leary, Junxiao Hu, Alexis Leal, S Lindsey Davis, Sunnie S Kim, Robert W Lentz, Tyler J Friedrich, Whitney Herter, Wells A Messersmith, Christopher H Lieu
Risk Without Reward: Differing Patterns of Chemotherapy Use Do Not Improve Outcomes in Stage II Early-Onset Colon Cancer. JCO oncology practice (2024)